Literature DB >> 24107317

STAT1/3 and ERK1/2 synergistically regulate cardiac fibrosis induced by high glucose.

Bin Dai1, Meng Cui, Mei Zhu, Wen-Ling Su, Ming-Cai Qiu, Hong Zhang.   

Abstract

BACKGROUND: Hyperglycaemia promotes the proliferation of cardiac fibroblasts (CFs) and collagen synthesis in CFs. However, the molecular mechanism underlying the effects of HG on proliferation and collagen synthesis of CF, is not completely understood.
OBJECTIVES: The objectives of the present study were to determine whether the STAT proteins has a functional role in high glucose-induced proliferation of CFs and collagen synthesis in vitro and whether the STAT signaling pathway and MAPK signaling pathway have synergetical effects on high glucose-mediated cardiac fibroblasts proliferation and collagen synthesis.
METHODS: Rat CFs were cultured in Dulbecco's modified Eagle's medium, supplemented with 5.5 or 25 mmol/L D-glucose, in the presence of absence of STAT1 inhibitor Fludarabine, STAT3 inhibitor S31-201 and ERK1/2 inhibitor PD98059. Proliferation were measured by the 3-(4,5-dimethyl-2 thiazoyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, the production of Type I and III collagen was evaluated using real-time quantitative RT-PCR and ELISA, and the phosphorylation expression of STAT1 and STAT3 were analyzed by Western blot.
RESULTS: High glucose treatment promoted the proliferation of cardiac fibroblasts and collagen types I and III synthesis. High glucose treatment induced STAT1 and STAT3 phosphorylation in cardiac fibroblasts, the mode and level of STAT1 and STAT3 phosphorylation were significantly different. Fludarabine and S31-201 could both inhibited high glucose stimulated proliferation of cardiac fibroblasts and collagen types I and III synthesis with different effects. Combination of Fludarabine and PD98059 or combination of S31-201 and PD98059 both exhibited stronger inhibitions on proliferation of cardiac fibroblasts and collagen types I synthesis, but the effects and functional modes are different.
CONCLUSION: Both STAT1 and STAT3 mediate the proliferation of cardiac fibroblasts and collagen synthesis induced by high glucose. STAT1 and STAT3 both have synergetic effects with ERK1/2 on regulating proliferation of cardiac fibroblasts and collagen types I synthesis.
© 2013 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24107317     DOI: 10.1159/000354499

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  20 in total

1.  RNAi screening identifies a mechanosensitive ROCK-JAK2-STAT3 network central to myofibroblast activation.

Authors:  Raymond S Oh; Andrew J Haak; Karry M J Smith; Giovanni Ligresti; Kyoung Moo Choi; Tiao Xie; Shaohua Wang; Paula R Walters; Michael A Thompson; Michelle R Freeman; Logan J Manlove; Vivian M Chu; Carol Feghali-Bostwick; Anja C Roden; Jürgen Schymeinsky; Christina M Pabelick; Y S Prakash; Robert Vassallo; Daniel J Tschumperlin
Journal:  J Cell Sci       Date:  2018-05-15       Impact factor: 5.285

2.  Myocyte-Derived Hsp90 Modulates Collagen Upregulation via Biphasic Activation of STAT-3 in Fibroblasts during Cardiac Hypertrophy.

Authors:  Ritwik Datta; Trisha Bansal; Santanu Rana; Kaberi Datta; Ratul Datta Chaudhuri; Mamta Chawla-Sarkar; Sagartirtha Sarkar
Journal:  Mol Cell Biol       Date:  2017-03-01       Impact factor: 4.272

3.  Allicin inhibits tubular epithelial-myofibroblast transdifferentiation under high glucose conditions in vitro.

Authors:  Hong Huang; Fenping Zheng; Xuehong Dong; Fang Wu; Tianfeng Wu; Hong Li
Journal:  Exp Ther Med       Date:  2016-11-18       Impact factor: 2.447

4.  STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.

Authors:  Mesias Pedroza; Thuy T Le; Katherine Lewis; Harry Karmouty-Quintana; Sarah To; Anuh T George; Michael R Blackburn; David J Tweardy; Sandeep K Agarwal
Journal:  FASEB J       Date:  2015-08-31       Impact factor: 5.191

5.  Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts.

Authors:  Xin Yi; Xiaoyan Li; Yanli Zhou; Shan Ren; Weiguo Wan; Gaoke Feng; Xuejun Jiang
Journal:  Int J Mol Med       Date:  2014-05-16       Impact factor: 4.101

Review 6.  Vitamin a deficiency and alterations in the extracellular matrix.

Authors:  Teresa Barber; Guillermo Esteban-Pretel; María Pilar Marín; Joaquín Timoneda
Journal:  Nutrients       Date:  2014-11-10       Impact factor: 5.717

7.  Differential Proteomics Identifies Reticulocalbin-3 as a Novel Negative Mediator of Collagen Production in Human Cardiac Fibroblasts.

Authors:  Ernesto Martínez-Martínez; Jaime Ibarrola; Amaya Fernández-Celis; Enrique Santamaria; Joaquín Fernández-Irigoyen; Patrick Rossignol; Frederic Jaisser; Natalia López-Andrés
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

8.  Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy.

Authors:  Christophe Chevillard; João Paulo Silva Nunes; Amanda Farage Frade; Rafael Ribeiro Almeida; Ramendra Pati Pandey; Marilda Savóia Nascimento; Jorge Kalil; Edecio Cunha-Neto
Journal:  Front Immunol       Date:  2018-12-03       Impact factor: 7.561

Review 9.  Effects of Cardiovascular Risk Factors on Cardiac STAT3.

Authors:  Márton Pipicz; Virág Demján; Márta Sárközy; Tamás Csont
Journal:  Int J Mol Sci       Date:  2018-11-12       Impact factor: 5.923

10.  Jia-Shen decoction-medicated serum inhibits angiotensin-II induced cardiac fibroblast proliferation via the TGF-β1/Smad signaling pathway.

Authors:  Lin Cui; Youping Wang; Rui Yu; Bin Li; Shiyang Xie; Yuan Gao; Xiaoxiao Wang; Mingjun Zhu
Journal:  Mol Med Rep       Date:  2016-06-16       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.